ABSTRACT
INTRODUCTION

Mucormycosis is rare fungal infection caused by several fungi, including
Mucor species, Rhizopus species and Absidia species. Recognized as one of the most rapidly progressive lethal form of fungal infection in humans with a high mortality of 25-62 percent. [1] [2] [3] [4] [5] [6] It occurs in severely ill patients with hallmark of the disease being vascular invasion with marked hemorrhagic necrosis. Among the conditions predisposing to Mucormycosis are diabetes mellitus, malnutrition, hematological malignancies, neutropenia, burns, surgical procedures, occlusive dressings, antibiotics, long term steroid therapy and immunosuppressive therapy. 4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The usual presentation is acute infection, first localized to rhino-cerebral area, gradually spread to surrounding areas, or even dissemination and affecting distant organs. In the case presented here the infection follows acute course, and somewhat indolent form which eventually caused maxillary necrosis. She was a diagnosed case of poorly controlled diabetes mellitus for four years, on irregular treatment with oral hypoglycemic drugs and insulin therapy. She has a history of surgical removal of right eye, for loss of vision and infection on right eye due to opportunistic diabetic infection. There is also history of admission due to diabetic ketoacidosis on three previous occasions. Her mother, was also a sufferer of Diabetes Mellitus Type two, and died due to its complications at the age of 52 years. Almost all patients with invasive mucormycosis have some underlying disease that both predisposes to the infection and influences the clinical presentation.
CASE REPORT
Rhizopus organisms have an enzyme, ketone reductase, which allows them to thrive in high glucose, acidic conditions. Serum from healthy individuals inhibits growth of Rhizopus, whereas serum from individuals in diabetic ketoacidosis stimulates growth. 5 The agents of mucormycosis are angioinvasive and infarction of infected tissues is a hallmark of invasive disease. 18, 19 A review of 929 cases of mucormycosis that were reported since 1940 noted that diabetes was the most common risk factor, found in 36 percent of cases, followed by hematologic malignancies (17 percent), and solid organ or hematopoietic stem cell transplantation (12 percent). 4 In some patients, mucormycosis was the diabetes-defining illness. 20 Mucormycosis is characterized by infarction and necrosis of host tissues that results from invasion of the vasculature by hyphae. Rhino-orbitalcerebral infection being most common clinical presentation is presumed to start with inhalation of spores into the paranasal sinuses of a susceptible host. Hyperglycemia, usually with an associated metabolic acidosis, is the most common underlying condition. 4 The infection presents as acute sinusitis with fever, nasal congestion, purulent nasal discharge, headache, and sinus pain. 20, 21 All of the sinuses become involved and spread to con- Deferoxamine, which chelates both iron and aluminum, increases the risk of mucormycosis by enhancing growth and pathogenicity. 8, 18, 22 The deferoxamine-iron chelate, called feroxamine, is a siderophore for the species Rhizopus, increasing iron uptake by the fungus, which stimulates fungal growth and leads to tissue invasion. 7, 8, 19 The diagnosis of mucormycosis relies upon the identification of organisms in tissue by histopathology with culture confirmation. However, culture often yields no growth, and histopathological identification of Despite early diagnosis and aggressive combined surgical and medical therapy, the prognosis for recovery from mucormycosis is poor. Overall mortality from rhino-orbital-cerebral mucormycosis ranges from 25 to 62 percent, with the best prognosis in patients with infection confined to the sinuses. 4, 17, 21, 22 The prognosis is especially poor for patients with brain, cavernous sinus or carotid involvement, although some patients with these complications have been cured of the infection. The outcome in patients with pulmonary mucormycosis is worse than for patients with rhino-orbital-cerebral involvement, with mortality rates as high as 87 percent.
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CONCLUSION
This case study highlights a rare case of mucormycosis of the paranasal sinuses in a relatively young diabetic patient. Depending on the underlying condition of immune compromised non hematological patients, mucormycosis can manifest in various clinical forms: mostly as rhino-orbital or rhino-cerebral in diabetes patients. Knowledge of the differential patterns of clinical presentation can raise the suspicion index for these rare but highly lethal infections. This is very important since prompt and appropriate management can reduce mortality and morbidity considerably. In the absence of large/tertiary health centers, treatment of this infection should be individualized. A multi-disciplinary team approach to identify early complications and sequelae is strongly recommended.
